首页/数据集/MC70 potentiates doxorubicin efficacy in colon and breast cancer in vitro treatment

MC70 potentiates doxorubicin efficacy in colon and breast cancer in vitro treatment

ChEBI2010-12-22 更新2026-07-21 收录

化疗联合治疗

体外药效评估

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-26250 数据链接链接失效反馈

官方服务：

资源简介：

MC70 potentiates doxorubicin efficacy in colon and breast cancer in vitro treatment

应用场景：

创建时间：

2010-12-22

黑色素瘤分子机制

化疗联合治疗

SK-MEL-2 cells treated with Ad-E2F-1 (MOI 2), Ad-E2F-1 (MOI 2)plus doxorubicin 0.1uM, or Ad-LacZ (MOI 2) plus doxorubicin 0.1uM. The combination of E2F-1 gene therapy and chemotherapy produces a syner

NIAID Data Ecosystem50

A synergistic approach to inhibit hepatocellular carcinoma cell proliferation

肿瘤药物协同治疗

体外药效评估

A novel L-shaped ortho-quinone analog and 2-Deoxy-D-Glucosea synergistic approach to inhibit hepatocellular carcinoma cell proliferation

Mendeley Data40

In-vitro evaluation of Nigella sativa and Punica granatum effect on protoscolices of hydatid cysts

寄生虫药物筛选

体外药效评估

Abstract Cystic echinococcosis (CE) are commonly found in the liver and lungs of affected hosts. The treatment approach is usually surgical, or giving drugs in conjunction before surgery to kill proto

Figshare2019-06-01 更新20

Table_4_Chidamide Reverses Fluzoparib Resistance in Triple-Negative Breast Cancer Cells.xlsx

三阴性乳腺癌耐药性

化疗联合治疗

Poly (ADP-ribose) polymerase inhibitor (PARPi) resistance is a new challenge for antitumor therapy. The purpose of this study was to investigate the reversal effects of chidamide on fluzoparib resista

NIAID Data Ecosystem40

Ex vivo adult S. mansoni worms after drug exposure.

血吸虫病药物

体外药效评估

Worms were exposed to S3A) no drug (negative control), S3B) 1 μM praziquantel, S3C) 30 μM pyronaridine, and S3D) 30 μM methylene blue, respectively, for 7 days followed by an additional 7 days without

Figshare2021-06-24 更新20

MC70 potentiates doxorubicin efficacy in colon and breast cancer in vitro treatment

资源简介：

相关数据集